Welcome to our dedicated page for Rhinebeck Bancorp SEC filings (Ticker: RBKB), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Rhinebeck Bancorp, Inc. filings document the public-company disclosures of a Maryland bank holding company for Rhinebeck Bank and its common stock listed on Nasdaq under RBKB. Form 8-K reports provide operating and financial results, including net interest income, expenses, credit-loss provisions and other bank performance measures.
Proxy materials cover annual meeting voting matters, board composition, governance and executive compensation. Registration statements and amendments address securities offering disclosures, the Rhinebeck Bank 401(k) Plan, capital structure and related risk factors for the company, Rhinebeck Bancorp, MHC and the bank.
Rhinebeck Bancorp, Inc. director William C. Irwin reported a grant/award acquisition of 10,000 shares of common stock on 2026-07-21 at 10.0000 per share. These shares are restricted stock that vest 33 1/3% per year beginning May 26, 2027. Following the award, he holds 50,937 common shares directly. He also holds fully vested stock options exercisable at 4.7000 per share for 15,250 underlying common shares, expiring on August 25, 2030. Share and option figures reflect a 1.3978 to 1.00 stock exchange ratio related to the company’s mutual to stock conversion.
Rhinebeck Bancorp, Inc. director Freddimir Garcia received a grant of 500 shares of restricted common stock at $10.00 per share on July 21, 2026. These restricted shares vest 33 1/3% per year starting May 26, 2027, bringing his direct common stock holdings to 7,206 shares.
Garcia also reports fully vested stock options covering 22,875 shares of common stock with an exercise price of $4.70 per share, expiring on August 25, 2030. Share and option figures reflect a 1.3978-to-1.00 exchange ratio from the company’s mutual-to-stock conversion.
Rhinebeck Bancorp, Inc. director Patzwahl Nancy Koskey reports direct ownership of 2,270 shares of common stock. This amount reflects a 1.3978-to-1.00 stock exchange ratio used in the company’s mutual to stock conversion, and footnotes describe restricted shares vesting 33 1/3% annually starting May 26, 2027.
Rhinebeck Bancorp, Inc. director Sharon McGinnis reports direct ownership of 2,270 shares of common stock. A footnote states this amount reflects a 1.3978-to-1 stock exchange ratio tied to the company’s mutual-to-stock conversion, and that these restricted shares vest in equal 33 1/3% annual installments beginning May 26, 2027.
Rhinebeck Bancorp, Inc. director Shannon Martin LaFrance received a grant of 2,700 shares of Common Stock as restricted stock at $10.00 per share. These shares vest 33 1/3% per year starting on May 26, 2027. After this award, she directly holds 35,341 common shares. She also holds fully vested stock options for 22,875 shares of common stock at an exercise price of $4.70 per share, expiring on August 25, 2030. Share amounts and option terms reflect a 1.3978-to-1.00 stock exchange ratio related to the company’s mutual to stock conversion.
Rhinebeck Bancorp, Inc. director Steven E. Howell reported his current equity positions. He holds 22875 stock options on common stock, with a fully vested status, an exercise price of $4.7000 and expiration on 2030-08-25. He also holds 9259 common shares directly and 6989 indirectly through a 401(k) plan. The share counts and option exercise price reflect a 1.3978 to 1.00 stock exchange ratio from the mutual-to-stock conversion, and shares of restricted stock vest at 33 1/3% per year beginning May 26, 2027.
Rhinebeck Bancorp, Inc. director Suzanne Loughlin reports direct ownership of 34,328 shares of Common Stock and fully vested stock options covering 22,875 shares at an exercise price of $4.7000 per share, expiring on August 25, 2030. These amounts reflect a 1.3978-to-1.00 stock exchange ratio from the company's mutual to stock conversion, and certain restricted shares vest 33 1/3% per year beginning May 26, 2027.
Rhinebeck Bancorp, Inc. executive Michael Vitale, EVP and Head of Commercial Banking, reported direct ownership of 12,580 shares of common stock. This amount reflects a 1.3978-to-1 stock exchange ratio from the company’s mutual to stock conversion and includes restricted shares vesting 33 1/3% annually starting April 21, 2027.
Rhinebeck Bancorp, Inc. director and President & CEO Matthew James Smith reported his beneficial ownership of Common Stock. He holds 23,826 shares directly and 479 shares indirectly through a 401(k) plan, amounts that reflect a 1.3978-to-1.00 stock exchange ratio in connection with the company’s mutual to stock conversion. Footnotes state that shares of restricted stock vest at 33 1/3% per year beginning May 26, 2027, and that the 401(k) position reflects transactions not required to be reported under Section 16.
Rhinebeck Bancorp, Inc. executive Kevin M. Nihill, CFO and Treasurer, reports direct ownership of 33,121 shares of common stock as of 2026-07-21. The position reflects a 1.3978-to-1.00 stock exchange ratio tied to the company’s mutual to stock conversion and includes restricted shares vesting 33 1/3% per year from grants beginning July 9, 2025 and May 26, 2027.
No share purchases or sales are shown; the report details his post-conversion and restricted stock holdings.